Summary
CRH plc has filed a Form 6-K, reporting a transaction involving its own shares on May 18, 2022. The company transferred 930 ordinary shares from treasury to a participant in an employee share scheme at a price of €16.19 per share. This transaction is part of CRH's ongoing management of its share capital, particularly in relation to employee incentives. Following this transfer, CRH plc now holds 10,477,864 ordinary shares in treasury. The total number of outstanding ordinary shares, excluding those held in treasury, stands at 763,662,474. This update is primarily informational for shareholders regarding the company's treasury stock and issued share count.
Key Highlights
- 1CRH plc reported a transaction in its own shares on May 18, 2022.
- 2930 ordinary shares were transferred from treasury to an employee share scheme participant.
- 3The transfer price was €16.19 per ordinary share.
- 4Following the transaction, CRH holds 10,477,864 ordinary shares in treasury.
- 5The total number of issued ordinary shares, excluding treasury shares, is 763,662,474.
- 6This filing is made under Form 6-K, indicating it's a report from a foreign private issuer.
Frequently Asked Questions
CRH plc transferred 930 of its own ordinary shares from its treasury stock to a participant in an employee share scheme at a price of €16.19 per share.
This transaction reduces the number of shares held in treasury and re-issues them. The total number of outstanding shares (excluding treasury shares) remains the same for the market, but the count of shares held in treasury decreases to 10,477,864, and the number of issued shares (excluding treasury) is 763,662,474.
Companies typically use treasury shares to fulfill obligations under employee stock options, stock purchase plans, or other equity-based compensation awards. It's a common practice to manage employee incentives without issuing new shares, which could dilute existing shareholders.
This transaction is primarily an administrative update related to share management and employee compensation. It does not represent a major strategic shift or have a direct, immediate impact on CRH's financial performance or profitability. Investors should view it as a routine operational disclosure.